Pediatric Drug Development – Visionary Promise Or Nightmare?

SAPhS PharmaLunch
Basel, January 26, 2018

Klaus Rose, M.D., M.S., klausrose Consulting, Pediatric Drug Development & More

– Chronological age, physiology, and why children are not „therapeutic orphans“
– Medical sense in FDA/EMA-demanded pediatric studies?
– Largest systematic abuse of patients in clinical research in history?
– Challenges for clinical community, media, lawyers, Ethics Committees/IRBs
– Ways forward


Logo of Swiss Academy of Pharmaceutical Sciences

You might also like